DNAマイクロアレイ市場- 世界の産業規模、動向、機会、予測、タイプ別、用途別、最終用途別、地域別、競合別セグメント、2019年～2029年

DNAマイクロアレイの世界市場は、2023年に18億4,431万米ドルとなり、2029年までのCAGRは8.27%で、予測期間中に目覚ましい成長を遂げると予測されています。

世界の市場セグメンテーション市場は、分子生物学とゲノミクスの分野でダイナミックかつ急速に発展している分野です。遺伝子チップやDNAチップとしても知られるDNAマイクロアレイは、研究者が何千もの遺伝子の発現レベルを同時に解析できる強力なツールです。遺伝子発現プロファイリング、ジェノタイピング、比較ゲノムハイブリダイゼーション、バイオマーカー探索など、さまざまな用途で重要な役割を果たしています。市場の成長はいくつかの要因によってもたらされます。個別化医療の普及と標的治療への需要の高まりが、疾患に関連する遺伝子変異の同定を容易にするDNAマイクロアレイの需要を促進しています。ゲノム研究、バイオインフォマティクス、データ解析の進歩はDNAマイクロアレイの能力を向上させ、より効率的で費用対効果の高いものとなっています。製薬およびバイオテクノロジーの分野では、潜在的な薬物標的の同定や薬物反応の予測など、創薬および薬剤開発のためにDNAマイクロアレイが広く使用されています。学術・研究機関では、遺伝子制御、疾病メカニズム、遺伝と環境の相互作用など、複雑な生物学的プロセスの研究にDNAマイクロアレイが使用されています。

2色マイクロアレイからマルチカラーマイクロアレイへの移行などの技術進歩により、応用範囲が拡大し、データ精度が向上。オープンソースのデータ解析ツールやデータベースが利用可能になり、DNAマイクロアレイ技術へのアクセスが民主化されました。その可能性にもかかわらず、DNAマイクロアレイ市場は、データの標準化、再現性、新たなハイスループットシーケンス技術との競合などの課題に直面しています。しかし、研究機関、業界関係者、規制機関の協力により、これらの課題に積極的に取り組んでいます。

主な市場促進要因

ゲノム研究の進展

診断アプリケーション

バイオマーカー探索

技術革新

主な市場課題

次世代シーケンサーとの競合

データの複雑性

主な市場動向

シングルセル解析

マルチオミクスの統合

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のDNAマイクロアレイ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（相補DNAマイクロアレイ、オリゴヌクレオチドDNAマイクロアレイ、その他）
  • 用途別（遺伝子発現解析、ジェノタイピング、その他）
  • 最終用途別（製薬・バイオテクノロジー企業、診断センター、病院・診療所、学術研究機関、その他）
  • 企業別（2023年）
  • 地域別
• 市場マップ

第6章 北米のDNAマイクロアレイ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 用途別
  • 最終用途別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州のDNAマイクロアレイ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 用途別
  • 最終用途別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋のDNAマイクロアレイ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 用途別
  • 最終用途別
  • 国別
• アジア太平洋：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米のDNAマイクロアレイ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 用途別
  • 最終用途別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのDNAマイクロアレイ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • 用途別
  • 最終用途別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併および買収（該当する場合）
• 製品の発売（ある場合）
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Thermo Fisher Scientific, Inc.
• QIAGEN NV
• Illumina, Inc.
• F. Hoffmann-La Roche Ltd.
• Agilent Technologies, Inc.
• Merck KGaA
• bioMerieux S.A.
• PerkinElmer Inc.
• Applied Micro Arrays Ltd.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global DNA Microarray Market was valued at USD 1844.31 million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.27% through 2029. The global DNA microarray market is a dynamic and rapidly evolving segment within the field of molecular biology and genomics. DNA microarrays, also known as gene chips or DNA chips, are powerful tools that enable researchers to analyze the expression levels of thousands of genes simultaneously. They play a crucial role in various applications, including gene expression profiling, genotyping, comparative genomic hybridization, and biomarker discovery. The market's growth is driven by several factors. The increasing adoption of personalized medicine and the demand for targeted therapies have fueled the demand for DNA microarrays, as they facilitate the identification of genetic variations associated with diseases. Advancements in genomics research, bioinformatics, and data analysis have enhanced the capabilities of DNA microarrays, making them more efficient and cost-effective. The pharmaceutical and biotechnology sectors extensively use DNA microarrays for drug discovery and development, including identifying potential drug targets and predicting drug responses.Academic and research institutions employ DNA microarrays for studying complex biological processes, such as gene regulation, disease mechanisms, and the interplay between genetics and environment.

Technological advancements, such as the transition from two-color to multi-color microarrays, have expanded the scope of applications and improved data accuracy. The growing availability of open-source data analysis tools and databases has democratized access to DNA microarray technology. Despite its potential, the DNA microarray market faces challenges such as data standardization, reproducibility, and competition from emerging high-throughput sequencing technologies. However, collaborations between research institutions, industry players, and regulatory bodies are actively addressing these challenges.

Key Market Drivers

Advancements in Genomic Research

Advancements in genomic research have significantly propelled the global DNA microarray market by expanding the understanding of genetic information and enabling a myriad of applications. Genomic research involves deciphering the complete set of genes and their functions within an organism's DNA. This deeper understanding of genetics has driven the development of DNA microarrays, which allow researchers to simultaneously analyze thousands of genes in a single experiment. These advancements have led to the identification of genetic variations associated with diseases, driving personalized medicine initiatives. DNA microarrays facilitate the analysis of gene expression patterns, revealing insights into disease mechanisms and potential therapeutic targets. This has transformed drug discovery, enabling the identification of candidate molecules and the assessment of their effects on gene expression.

DNA microarrays have played a pivotal role in deciphering complex biological processes, such as signaling pathways, gene regulation, and interactions between genes and environmental factors. They aid in characterizing the genetic basis of diseases, enabling the discovery of novel biomarkers for early disease detection and prognosis. As genomic research continues to evolve, the demand for DNA microarrays is expected to grow. Advancements in microarray technology, including improved sensitivity, higher throughput, and single-cell analysis capabilities, are enhancing the precision and scope of genomic studies. These developments hold the potential to uncover deeper insights into the intricate workings of genes, contributing to advancements in medicine, agriculture, biotechnology, and more.

Diagnostic Applications

Diagnostic applications are a significant and rapidly expanding area within the global DNA microarray market. DNA microarrays are instrumental in diagnosing various diseases and conditions by analyzing genetic information. They provide insights into gene expression patterns, genetic mutations, and variations that are associated with specific diseases. In the realm of clinical diagnostics, DNA microarrays are used to profile gene expression in patient samples, helping identify molecular signatures indicative of diseases like cancer. These molecular profiles assist in accurate disease classification, prognosis, and treatment selection. DNA microarrays aid in detecting genetic mutations linked to hereditary disorders, enabling early identification and intervention. In infectious disease diagnostics, DNA microarrays facilitate the rapid and simultaneous detection of multiple pathogens, such as viruses and bacteria, in patient samples. This efficient screening can accelerate the diagnosis and management of infectious outbreaks.

The versatility of DNA microarrays extends to pharmacogenomics, where they guide personalized medicine by predicting an individual's response to specific drugs based on genetic variations. This enhances treatment efficacy, minimizes adverse reactions, and optimizes drug dosages. The impact of DNA microarrays in prenatal testing is also notable. They enable non-invasive prenatal testing by analyzing fetal DNA from maternal blood, aiding in the detection of chromosomal abnormalities and genetic disorders in the developing fetus. As technology advances, the applications of DNA microarrays in diagnostics continue to expand. The ability to analyze large-scale genetic data with precision and speed holds immense promise for revolutionizing disease diagnosis, patient care, and public health initiatives on a global scale.

Biomarker Discovery

Biomarker discovery is a critical aspect of the global DNA microarray market, revolutionizing disease diagnosis, treatment, and personalized medicine. Biomarkers are specific molecules or genetic signatures that indicate the presence or progression of a disease, as well as the response to treatments. DNA microarrays play a pivotal role in identifying these biomarkers by analyzing gene expression patterns and genetic variations across thousands of genes simultaneously. In the context of disease research, DNA microarrays enable the comprehensive profiling of gene expression in healthy and diseased tissues. By comparing these profiles, researchers can pinpoint genes that are overexpressed or underexpressed in disease states. These dysregulated genes often serve as potential biomarkers for early disease detection, prognosis, and monitoring treatment responses.

Biomarker discovery using DNA microarrays has far-reaching implications. It aids in tailoring treatment strategies to individual patients based on their genetic profiles, optimizing therapy effectiveness and minimizing adverse effects. It accelerates drug development by identifying biomarkers that can be targeted by new therapies, streamlining clinical trials and drug approval processes. The integration of bioinformatics and advanced data analysis techniques with DNA microarrays enhances biomarker discovery by deciphering complex genetic interactions and networks. This multidimensional approach accelerates the identification of biomarkers with clinical relevance. Ultimately, biomarker discovery through DNA microarrays transforms medical practice by enabling early disease detection, guiding treatment decisions, and contributing to the development of precision medicine approaches that are revolutionizing patient care globally.

Technological Innovations

Technological innovations have significantly propelled the global DNA microarray market by enhancing the capabilities, efficiency, and applications of this powerful tool. These innovations encompass a range of advancements that have transformed how DNA microarrays are designed, manufactured, and utilized. One key innovation is the development of high-density microarrays, which allow for the simultaneous analysis of tens of thousands of genetic targets. This increased capacity has enabled researchers to explore complex biological phenomena with unprecedented detail, leading to more comprehensive insights into gene expression, genetic variations, and disease mechanisms. Single-cell analysis technologies have revolutionized DNA microarrays by enabling the study of individual cells' genetic profiles. This advancement has unveiled previously hidden cellular heterogeneity and has profound implications for understanding development, disease progression, and treatment responses at a finer resolution.

Automation and robotics have streamlined the manufacturing and operation of DNA microarrays, making high-throughput analyses more accessible and cost-effective. These technologies have expedited research and diagnostics, enabling researchers to process larger volumes of samples and generate data more efficiently. Incorporation of bioinformatics tools and data analysis software has been instrumental in managing and interpreting the vast amount of genetic data generated by DNA microarrays. Advanced algorithms can identify meaningful patterns, biomarkers, and genetic pathways from complex datasets, enhancing researchers' ability to derive actionable insights. Overall, these technological innovations have not only expanded the capabilities of DNA microarrays but have also democratized access to this technology. This has resulted in broader adoption across diverse research fields, from genomics and medicine to agriculture and biotechnology, fueling discoveries and advancements with far-reaching implications.

Key Market Challenges

Competition from Next-Generation Sequencing

Competition from next-generation sequencing (NGS) presents a significant challenge to the global DNA microarray market. NGS technologies have rapidly advanced in recent years, offering comprehensive and high-throughput analysis of genetic material. This advancement has led to a shift in research preferences and funding allocation, affecting the adoption and growth of DNA microarray technology. NGS allows researchers to sequence entire genomes, transcriptomes, or specific regions of interest with unprecedented accuracy and depth. This comprehensive approach provides a wealth of genetic information, enabling researchers to explore genetic variations, mutations, and gene expression profiles in greater detail compared to DNA microarrays.

One key advantage of NGS is its ability to provide unbiased and genome-wide data, making it suitable for a wide range of applications, from basic research to clinical diagnostics and personalized medicine. This versatility has led to increased interest and investment in NGS platforms, potentially diverting resources and attention away from DNA microarrays. NGS technologies offer a higher degree of flexibility and customization compared to commercial DNA microarrays. Researchers can design custom sequencing panels to target specific genes or regions of interest, eliminating the limitations of predefined microarray content. The competition from NGS has prompted a reevaluation of research priorities and funding allocation, especially in genomics and genetic studies. Researchers are increasingly opting for NGS platforms to address their research questions due to its broader applicability and ability to generate more detailed insights into genetic variations.

Data Complexity

Data complexity is a significant challenge in the global DNA microarray market that arises from the vast amount of genetic information generated by these technologies. DNA microarrays simultaneously measure the expression levels of thousands of genes in a single experiment, producing intricate datasets that require sophisticated analysis techniques and bioinformatics tools to extract meaningful insights. DNA microarrays generate data with a high dimensionality, as each gene's expression is measured across multiple samples. Managing and analyzing this multi-dimensional data matrix requires specialized computational approaches. Biological and technical variations introduce noise and variability into the data, making it challenging to distinguish true signals from random fluctuations. Robust statistical methods are essential to identify meaningful changes in gene expression. DNA microarray data must undergo normalization to account for differences in sample preparation, labeling, and hybridization efficiency.

Failure to properly normalize data can lead to misleading results. When experiments are conducted in different batches or on different days, batch effects can introduce systematic variations that need to be corrected to ensure accurate interpretation of results. Combining data from multiple experiments or platforms can be complex due to differences in experimental conditions and data formats. Effective integration requires careful consideration of normalization and scaling techniques. Analyzing DNA microarray data demands a strong grasp of bioinformatics and data analysis techniques. Researchers need to choose appropriate algorithms, perform quality control, and interpret the results correctly. Addressing data complexity involves the development and application of advanced computational tools, machine learning algorithms, and statistical methods tailored to DNA microarray data.

Key Market Trends

Single-Cell Analysis

Single-cell analysis is a revolutionary approach in the field of genomics and is significantly impacting the global DNA microarray market. Traditionally, genomics studies involved analyzing a mixture of cells, which averaged out gene expression levels across populations. Single-cell analysis, however, allows researchers to study individual cells separately, uncovering previously hidden cellular heterogeneity and enabling a deeper understanding of complex biological processes. DNA microarrays are being adapted for single-cell analysis, offering a powerful tool to investigate gene expression patterns, genetic variations, and epigenetic modifications at the resolution of single cells. This technology provides insights into how individual cells within a population respond to stimuli, develop, differentiate, and contribute to diseases.

Researchers are using single-cell DNA microarrays to study various biological phenomena, such as embryonic development, immune responses, neuronal diversity, and cancer heterogeneity. This approach has profound implications for personalized medicine, as it enables the identification of rare cell types, the characterization of disease-specific cell populations, and the discovery of new biomarkers. Despite challenges, such as the small amount of genetic material in a single cell, DNA microarrays are being designed with higher sensitivity and precision to accommodate single-cell applications. Bioinformatics tools play a critical role in analyzing the complex data generated from these experiments, identifying gene expression patterns and correlations across individual cells. Overall, single-cell analysis using DNA microarrays is transforming our understanding of cellular diversity and function, paving the way for breakthroughs in biology, disease research, and therapeutic development. As this trend continues to gain momentum, it is reshaping the landscape of genomics and expanding the capabilities of the global DNA microarray market.

Multi-Omics Integration

Multi-omics integration is a pivotal trend in the global DNA microarray market that involves combining data from various omics disciplines, such as genomics, transcriptomics, proteomics, and metabolomics, to gain a holistic and comprehensive understanding of complex biological systems. This approach recognizes that biological processes are intricately interconnected and studying them in isolation provides only a partial view. DNA microarrays play a crucial role in multi-omics integration by providing a platform to analyze gene expression patterns across thousands of genes simultaneously. Integrating DNA microarray data with other omics data sets allows researchers to uncover correlations, interactions, and regulatory networks that provide deeper insights into biological processes, disease mechanisms, and drug responses. This can provide a more accurate picture of cellular responses and disease pathways.

Combining DNA microarray data with metabolomics data can reveal how genetic variations influence metabolic pathways and impact disease phenotypes. Multi-omics integration enhances our ability to identify biomarkers for diseases, predict treatment responses, and develop targeted therapies. This approach is particularly important in personalized medicine, where a patient's genetic, transcriptomic, proteomic, and metabolomic profiles are considered to tailor treatments to their unique molecular characteristics. The success of multi-omics integration relies on advanced bioinformatics tools and computational algorithms that can handle diverse data types, perform cross-omics analyses, and identify meaningful patterns and correlations. As this trend continues to evolve, the global DNA microarray market is witnessing a shift towards more comprehensive and systems-level approaches, accelerating discoveries in biology, disease research, and therapeutic development.

Segmental Insights

Type Insights

In 2023, the DNA Microarray Market was predominantly led by the oligonucleotide DNA microarrays segment, a trend poised to persist and flourish in the upcoming years. This dominance can be attributed to several key factors driving the growth and preference for oligonucleotide-based microarrays. One significant reason is the versatility and specificity offered by oligonucleotide probes. These probes are designed to precisely target and detect complementary DNA or RNA sequences, enabling researchers to achieve high levels of accuracy in their analyses. This accuracy is crucial in various applications, from gene expression profiling to mutation detection, where researchers require reliable and reproducible results.

Oligonucleotide microarrays often boast enhanced sensitivity compared to other types, such as cDNA microarrays. This heightened sensitivity allows for the detection of low-abundance transcripts, providing researchers with a more comprehensive view of gene expression patterns. The ability to capture subtle changes in gene expression is invaluable in fields like cancer research, where identifying biomarkers or therapeutic targets necessitates a deep understanding of gene activity.

Oligonucleotide microarrays are known for their scalability and ease of customization. Researchers can design arrays tailored to their specific experimental needs, whether studying a handful of genes or conducting whole-genome analyses. This flexibility attracts scientists across diverse disciplines, from biotechnology to pharmacogenomics, who seek personalized and efficient solutions for their research endeavors.

Application Insights

The gene expression analysis segment led the DNA microarray market in 2023. This growth is driven by the adoption of gene expression in diverse applications such as clinical diagnostics, drug discovery, and microbiology. The use of gene expression in various drug discovery processes has surged significantly in recent years. Additionally, the advantages of DNA microarrays over other technologies and the broad scope of gene expression analysis have fueled the demand for this technology across multiple end-use applications.

Conversely, the genotyping segment is projected to experience substantial growth during the forecast period. Factors such as increased R&D funding for precision medicine, rising prevalence of target diseases, and strategic initiatives by market players are expected to drive this growth. For example, in February 2021, 23andMe merged with VG Acquisition Corp., providing capital to support their genetic consumer health business and genetic research activities.

Regional Insights

In 2023, the Global DNA Microarray Market witnessed dominance from the North America region, a trend expected to persist and expand in the years ahead. Several factors contribute to North America's stronghold in this market. The region boasts a robust infrastructure for biomedical research, with a concentration of leading research institutions, biotech companies, and pharmaceutical firms. This rich ecosystem fosters a high demand for DNA microarray technologies, driving market growth.

North America is at the forefront of genomics and personalized medicine initiatives. The region's healthcare landscape places a strong emphasis on precision medicine, which relies heavily on genomic analysis for diagnostics, treatment decisions, and drug development. DNA microarrays play a pivotal role in these applications, enabling researchers and clinicians to analyze large sets of genetic information rapidly and comprehensively.

The presence of key market players and technological innovators in North America contributes significantly to market dominance. The region is home to major companies specializing in DNA microarray technologies, fostering a competitive environment that spurs innovation and product development. This concentration of expertise and resources further cements North America's position as a leader in the global DNA microarray market.

Favorable regulatory policies and government initiatives supporting genomics research and biotechnology in North America create an environment conducive to market growth. Funding opportunities, research grants, and collaborations between academia and industry fuel advancements in DNA microarray technology, propelling the market forward.

Key Market Players

Thermo Fisher Scientific, Inc.

QIAGEN NV

Illumina, Inc.

F. Hoffmann-La Roche Ltd.

Agilent Technologies, Inc.

Merck KGaA

bioMerieux S.A.

PerkinElmer, Inc.

Applied Micro Arrays Ltd.

Report Scope:

In this report, the Global DNA Microarray Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

DNA Microarray Market, By Type:

Complementary DNA Microarrays Oligonucleotide DNA Microarrays Others

DNA Microarray Market, By Application:

Gene Expression Analysis Genotyping Others

DNA Microarray Market, By End Use:

Pharmaceutical and Biotechnology Companies Diagnostic Centers Hospitals and Clinics Academic and Research Institute Others

DNA Microarray Market, By Region:

North America
• United States
• Canada
• Mexico
Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
South America
• Brazil
• Argentina
• Colombia
Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global DNA Microarray Market.

Available Customizations:

Global DNA Microarray Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global DNA Microarray Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Complementary DNA Microarrays, Oligonucleotide DNA Microarrays, Others)
  • 5.2.2. By Application (Gene Expression Analysis, Genotyping, Others)
  • 5.2.3. By End Use (Pharmaceutical and Biotechnology Companies, Diagnostic Centers, Hospitals and Clinics, Academic and Research Institute, Others)
  • 5.2.4. By Company (2023)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America DNA Microarray Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States DNA Microarray Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End Use
  • 6.3.2. Mexico DNA Microarray Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End Use
  • 6.3.3. Canada DNA Microarray Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End Use

7. Europe DNA Microarray Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France DNA Microarray Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End Use
  • 7.3.2. Germany DNA Microarray Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom DNA Microarray Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy DNA Microarray Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain DNA Microarray Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End Use

8. Asia-Pacific DNA Microarray Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China DNA Microarray Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End Use
  • 8.3.2. India DNA Microarray Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End Use
  • 8.3.3. South Korea DNA Microarray Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End Use
  • 8.3.4. Japan DNA Microarray Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia DNA Microarray Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End Use

9. South America DNA Microarray Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil DNA Microarray Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End Use
  • 9.3.2. Argentina DNA Microarray Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End Use
  • 9.3.3. Colombia DNA Microarray Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End Use

10. Middle East and Africa DNA Microarray Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa DNA Microarray Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End Use
  • 10.3.2. Saudi Arabia DNA Microarray Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End Use
  • 10.3.3. UAE DNA Microarray Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. QIAGEN NV
• 14.3. Illumina, Inc.
• 14.4. F. Hoffmann-La Roche Ltd.
• 14.5. Agilent Technologies, Inc.
• 14.6. Merck KGaA
• 14.7. bioMerieux S.A.
• 14.8. PerkinElmer Inc.
• 14.9. Applied Micro Arrays Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer